Skip to main content
SpringerLink
Log in

Herzinsuffizienz

  • Chapter
Pharmakotherapie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 2814 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • ALLHAT Collaborative Research Group (2000) ALLHAT-Studie.: Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283: 1967–75

    Article  Google Scholar 

  • CIBIS II Study (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353: 9

    Article  Google Scholar 

  • Cleland JG et al. (2005) Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med. 352: 1539

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN et al. (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314: 1547

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN et al. (1991) A comparison of enalapril with hydralazin-isosorbide dinitrate in the treatment of congestive heart failure. N Engl J Med 325: 303

    Article  PubMed  CAS  Google Scholar 

  • Cohn JN, Tognoni G (2001) Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345: 1667–75

    Article  PubMed  CAS  Google Scholar 

  • Colucci WS et al. (2000) Intravenous nesiritide, a natriuretic peptide, in the treatment of decomensated congestive heart failure. Nesiritide Study Group. N. Engl. J. Med. 343: 246

    Article  PubMed  CAS  Google Scholar 

  • Cooper HA et al. (1999) Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 100: 1311

    PubMed  CAS  Google Scholar 

  • Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336: 525

    Article  Google Scholar 

  • Flather MD et al. SENIORS Investigators (2005) Randomized trail to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur. Heart J. 26: 215

    Article  PubMed  CAS  Google Scholar 

  • Gottlieb SS, McCarter RJ, Vogel RA (1998) Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339: 489–497

    Article  PubMed  CAS  Google Scholar 

  • Granger CB et al. (2003) CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 362: 772–776

    Article  PubMed  CAS  Google Scholar 

  • Hoppe UC et al. für die Kommission für Klinische Kardiologie der Deutschen Gesellschaft für Kardiologie (2005) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z. Kardiol. 94: 488

    Article  PubMed  CAS  Google Scholar 

  • Lader E, Egan D, Hunsberger S et al. (2003) The effect of digoxin on the quality of life in patients with heart failure. J Card Fail 9: 4–12

    Article  PubMed  CAS  Google Scholar 

  • MERIT-HF-Study (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure. Lancet 12, 353: 2001

    Google Scholar 

  • Packer M et al. (1991) Effects of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 325: 1468

    Article  PubMed  CAS  Google Scholar 

  • Packer M et al. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349

    Article  PubMed  CAS  Google Scholar 

  • Packer M et al. for the RADIANCE Study (1993) Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N Engl J Med 329: 1

    Article  PubMed  CAS  Google Scholar 

  • Page J, Henry D (2000) Consumption of NSAIDs and the development of Congestive Heart Failure in Elderly Patients: An Underrecognized Public Health

    Google Scholar 

  • Pfeffer MA et al. (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both (VALIANT). N Engl J Med. 349: 1893

    Article  PubMed  CAS  Google Scholar 

  • Pitt B et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators (RALES). N Engl J Med 341: 709

    Article  PubMed  CAS  Google Scholar 

  • Pitt B et al. (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial. The Losartan Heart Failure Survival Study ELITE II. Lancet 355, 1582–1587

    Article  PubMed  CAS  Google Scholar 

  • Pitt B et al. (2003) Eplerenone post-acute myocardial in-farction heart failure efficacy and survival study investigators. N Engl J Med 348: 1309–1321

    Article  PubMed  CAS  Google Scholar 

  • Poole-Wilson PA et al. (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Carvedilol Or Metoprolol European Trial Investigators. Lancet 362: 7–13

    Article  PubMed  CAS  Google Scholar 

  • Rathore SS, Curtis JP, Wang Y et al. (2003) Association of serum digoxin concentration and outcomes in patients with heart failure. AMA 289: 871–878

    CAS  Google Scholar 

  • Rau T et al. (2002) Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment. Pharmacogenetics 12: 465–472

    Article  PubMed  CAS  Google Scholar 

  • SOLVD investigators (1992) Effect of enalapril on mortality and the develop-ment of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 327: 685

    Article  Google Scholar 

  • Taylor AL et al. African-American Heart Failure Trail Investigators (2004) Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N. Engl. J. Med. 351: 2049

    Article  PubMed  CAS  Google Scholar 

  • The Consensus Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. N. Engl. J. Med. 316: 1429

    Article  Google Scholar 

  • Topol EJ (2005) Nesiritide-not verified. N. Engl. J. Med. 353: 133

    Article  Google Scholar 

  • VMAC, Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF) (2002) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trail. JAMA 287: 1531

    Article  Google Scholar 

  • Waldo AL et al. (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348: 7

    Article  PubMed  CAS  Google Scholar 

  • Willenheimer R et al. (2005) Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 112: 2426

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Experimentelle und Klinische Pharmakologie, Zentrum für Experimentelle Medizin, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg

    Prof. Dr. med. Thomas Eschenhagen

  2. Klinik III für Innere Medizin, Universität zu Köln, Kerpener Str. 62, 50924, Köln

    Prof. Dr. med. Erland Erdmann

Authors
  1. Prof. Dr. med. Thomas Eschenhagen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Erland Erdmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie und Toxikologie, Fakultät für Klinische Medizin Mannheim, Ruprecht-Karls-Universität Heidelberg, Maybachstraße 14, 68169, Mannheim

    Björn Lemmer

  2. Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstraße 22, 91054, Erlangen

    Kay Brune

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Eschenhagen, T., Erdmann, E. (2007). Herzinsuffizienz. In: Lemmer, B., Brune, K. (eds) Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34181-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34181-9_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34180-2

  • Online ISBN: 978-3-540-34181-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation